“[￦￦￦닷 yeotop3.com ] ◐친해진◑소요산스파Ⅰ소요산건마♝소요산휴게텔✂소요산키스방❧소요산립카페ゑ소요산풀싸롱♐소요산OP”的搜索结果，显示 401-410 项，共有 12883 项

1. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

2. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in hospitalized malignant ...

4. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 神经科- 临床试验- 妙佑医疗国际

   Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma ... Jacksonville, Fla. This study aims to evaluate the safety of local delivery of AMSCs ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...